Menene Maganin Regenokine kuma Shin Yana Aiki?

Wadatacce

• Menene Regenokine?
• Menene tsarin Regenokine ya ƙunsa?
• Jinin ku za a zana
• Za a sarrafa jininka
• Za a sake shigar da jininka a cikin mahaɗin da abin ya shafa
• Babu lokacin dawowa da ake buƙata
• Ta yaya Regenokine ke aiki?
• Shin Regenokine yana da tasiri?
• Me yasa Regenokine baya aiki ga kowa?
• Abin da karatun ya ce
• Mutum nawa aka yiwa magani?
• Yaya game da farfadowa da guringuntsi?
• Menene bambanci tsakanin Regenokine da PRP far?
• Regenokine yana amfani da daidaitaccen tsarin sarrafawa
• Regenokine yana cire ƙwayoyin jini da sauran abubuwa masu haɗari
• Shin Regenokine lafiya?
• Nawa ne kudin Regenokine?
• Ba inshora ya rufe shi a Amurka ba
• Har yaushe maganin Regenokine zai wuce?
• A ina zan sami ƙwararren mai ba da sabis?
• Awauki

Regenokine magani ne mai ƙin kumburi don haɗin gwiwa da kumburi. Hanyar yin allurar amfani da sunadarai da aka tattara daga jininka a cikin mahaɗarku.

Dokta Peter Wehling, wani likita ne dan asalin kasar Jamus, wanda ya yi aikin likitan kashin baya, ne ya samar da maganin, kuma an amince da amfani da shi a nan Jamus. Yawancin fitattun 'yan wasa, ciki har da Alex Rodriguez da Kobe Bryant, sun yi tafiya zuwa Jamus don yin maganin Regenokine kuma sun ba da rahoton cewa yana saukaka ciwo.

Kodayake ba a yarda da Regenokine ba tukuna ta Hukumar Abinci da Magunguna (FDA), an yi amfani da lakabin kashewa a shafuka uku a Amurka waɗanda Wehling ke da lasisi.

Regenokine yayi kama da maganin cutar plasma mai arzikin platelet (PRP), wanda ke amfani da kayan jininka don taimakawa sake sabunta nama a yankin da aka ji rauni.

A cikin wannan labarin, za mu sake nazarin yadda tsarin Regenokine yake, yadda ya bambanta da PRP, da kuma yadda tasirinsa yake don magance ciwo.

Menene Regenokine?

A farkon ci gaban Regenokine, Wehling ya sami nasarar kula da dawakan Larabawa waɗanda suka sami raunin haɗin gwiwa. Bayan ya ci gaba da bincikensa tare da mutane, an amince da kirkirar Wehling don amfanin mutum a cikin 2003 ta Jamusanci daidai da FDA.

Hanyar tana tattara sunadarai a cikin jininka wanda ke yaki da kumburi da kuma inganta farfadowa. Bayanin da aka sarrafa sai a sake mayar da shi cikin mahaɗin da abin ya shafa. Jinin ba shi da jajayen ƙwayoyin jini ko fararen ƙwayoyin jini wanda zai iya haifar da damuwa.

Hakanan za'a iya kiran magani mai kwantaccen magani, ko ACS.

Menene tsarin Regenokine ya ƙunsa?

Kafin aikin, ƙwararren Regenokine zai yi aiki tare da mai ba da sabis na kiwon lafiya na farko don sanin ko kai ɗan takara ne na wannan maganin. Zasu yanke shawarar su ta hanyar binciken daidaitaccen aikin jinin ku da kuma hotunan raunin ku.

Idan kun sami ci gaba, ga abin da zaku yi tsammani yayin aikin:

Jinin ku za a zana

Wani likita zai zana kimanin oza 2 na jini daga hannunka. Wannan yana ɗaukar mintoci kaɗan.

Za a sarrafa jininka

Za a ɗaga zafin zafin jikin jinin kaɗan har zuwa awanni 28 a cikin yanayin janaba. Daga nan za'a sanya shi a cikin centrifuge zuwa:

• raba kayan jini
• tattara sunadaran anti-inflammatory
• createirƙiri magani mara salula

Dogaro da yanayinku, za a iya ƙara wasu sunadaran zuwa cikin jinin.

A cewar Dokta Jana Wehling, wata likitan kashi da kuma masaniyar rauni da ke aiki tare da mahaifinta a asibitin Regenokine da ke Dusseldorf, Jamus, "Additionarin cikin maganin ya haɗa da sunadarai masu haɗuwa kamar IL-1 Ra, maganin sa maye na cikin gida, ko kuma ƙananan ƙwayoyin cuta na cortisone."

Samfurin da aka yiwa magani ya daskarewa sannan a sanya shi a cikin allurai don allura.

Za a sake shigar da jininka a cikin mahaɗin da abin ya shafa

A reinjection tsari daukan 'yan mintoci. Peter Wehling kwanan nan ya gabatar da wata dabara don allura guda (Regenokine® One Shot), maimakon allurar guda ɗaya kowace rana tsawon kwanaki 4 ko 5.

Dikita na iya amfani da duban dan tayi a matsayin taimakon hoto don sanya wurin allurar daidai.

Idan magani ya rage, ana iya daskarewa don amfani a gaba.

Babu lokacin dawowa da ake buƙata

Babu wani ɓacin lokaci da ke bin hanyar. Za ku iya ci gaba da ayyukanku nan da nan bayan sakewa.

Lokacin da zaka dauka don jin sauƙin ciwo da kumburi ya bambanta da mutum.

Ta yaya Regenokine ke aiki?

A cewar Peter Wehling, Maganin Regenokine da aka yi wa magani ya ninka har sau dubu 10,000 na yawan furotin na anti-inflammatory. Wannan furotin din, wanda aka sani da antagonukin mai karɓar rashi mai karɓa (IL-1 Ra), yana toshe takwaransa mai haifar da kumburi, interleukin 1.

Dokta Christopher Evans, darektan Cibiyar Nazarin Magungunan Rashin Lafiya a Mayo Clinic, ya bayyana ta wannan hanyar: “‘ Bad interleukin, ’interleukin 1, yana haɗuwa da takamaiman abin da ke karɓar maganin a saman tantanin da zai amsa masa. Yana tashar jirgin ruwa a can. Kuma bayan wannan, dukkan munanan abubuwa suna faruwa. ”

"Kyakkyawan interleukin," in ji Evans, "shine mai karɓar mai karɓar mai karɓa na interleukin-1. Wannan yana toshe mai karɓar (cell). … Kwayar ba ta ganin interleukin-1, saboda an toshe ta, sabili da haka, mummunan abubuwa ba sa faruwa. ”

Anyi tunanin cewa IL-1 Ra na iya magance abubuwan da ke haifar da guringuntsi da lalacewar nama da kuma osteoarthritis.

Shin Regenokine yana da tasiri?

Nazarin Regenokine ya nuna cewa yana da tasiri a cikin yawancin mutane, amma ba duka ba.

Kayan asibitin Wehling sun bayyana cewa suna daukar maganin Regenokine cikin nasara lokacin da ciwon mara lafiya ko aiki ke inganta da kashi 50. Suna amfani da tambayoyi na yau da kullun ga mutanen da suke da maganin don kimanta tasirinsa.

Asibitin ya kiyasta cewa kimanin kashi 75 cikin 100 na mutanen da ke fama da cutar sanyin gwiwa da ciwan baya za su yi nasara tare da maganin.

Likitocin Amurka da aka basu lasisin amfani da Regenokine suna da irin wannan nasarar. An nuna don jinkirta buƙatar maye gurbin haɗin gwiwa, ko don guje wa buƙatar maye gurbin haɗin gwiwa a cikin wasu mutane.

Me yasa Regenokine baya aiki ga kowa?

Mun tambayi Evans, wanda ya yi aiki tare da Peter Wehling a farkon bincikensa, me yasa Regenokine ke aiki ga yawancin mutane amma ba na kowa ba. Ga abin da ya ce:

“Osteoarthritis ba cuta ce mai kama da mutum daya ba. Ya zo a cikin bambance-bambancen da yawa kuma mai yiwuwa ne cewa akwai nau'ikan subtyty, wasu daga cikinsu zasu amsa, wasu kuma ba. Dokta Wehling ya kirkiro wani algorithm don wannan ta amfani da abubuwa daban-daban na DNA mai haƙuri. An yi hasashen mutanen da ke da wasu jerin DNA za su zama masu iya amsawa. ”

Dokta Thomas Buchheit, MD, CIPS, darekta na farfado da cututtukan cututtuka a Jami'ar Duke - ɗayan shafuka uku a Amurka waɗanda ke da lasisi don amfani da maganin da Wehling ya haɓaka - ya kuma lura cewa, “Muna ganin kyakkyawan sakamako tare da mutanen da suka suna da ciwon sikila mai sauƙi zuwa matsakaici, ba ƙashi a ƙashi ba. ”

Abin da karatun ya ce

Studiesananan karatu sun kalli maganin Regenokine, wanda kuma ake magana da shi azaman magani mai kwakwalwa (ACS), don ciwon haɗin gwiwa. Wasu suna kwatanta shi da sauran jiyya. Sauran karatun suna kallon takamaiman haɗin gwiwa.

Anan ga 'yan karatun kwanan nan:

• Nazarin 2020 na mutane 123 da ke fama da cutar sanyin kashi idan aka kwatanta ACS da maganin PRP. Binciken ya gano cewa maganin ACS ya yi tasiri kuma “ya fi ƙarfin PRP.” Mutanen da suka karɓi ACS suna da mafi rage rage ciwo da haɓaka aiki fiye da waɗanda ke da PRP.
• Wani daga cikin mutane 28 tare da gwiwa ko osteoarthritis na hip ya gano cewa maganin ACS ya haifar da "saurin ci gaba da ciwo" da kuma karuwar kewayon motsi.
• Wani maganin sake warkewa ya kwatanta Regenokine tare da sauran maganin farfadowa. Yana bayar da rahoton cewa ACS "yana rage ciwo da haɗin gwiwa a cikin cututtukan gabbai."
• Wani daga cikin mutanen 47 tare da raunin meniscus da aka bi ya gano cewa ACS ta samar da ingantaccen tsarin tsari bayan watanni 6. A sakamakon haka, an kauce wa tiyata a cikin kashi 83 cikin 100 na shari'ar.
• Wani gwiwoyi na 118 da aka bi da ACS ya sami saurin ci gaba a cikin ciwo da aka ci gaba tsawon shekaru 2 na binciken. Mutum ɗaya ne kawai ya karɓi maye gurbin gwiwa yayin nazarin.

Mutum nawa aka yiwa magani?

A cewar Jana Wehling, "Shirin na Regenokine ya kasance yana amfani da asibiti kusan shekaru 10 kuma an kiyasta kimanin marasa lafiya 20,000 a duniya."

An yi amfani da ƙarni na farko na Regenokine, Orthokine, don magance fiye da marasa lafiya 100,000, in ji ta.

Yaya game da farfadowa da guringuntsi?

Kamar yadda Evans ya sanya shi, sabuntawar guringuntsi shine tsarkaka mai tsarki ga mutanen da ke aiki tare da osteoarthritis. Shin Regenokine zai iya sake haifar da guringuntsi? Tambaya ce a ƙarƙashin bincike ta Peter Wehling da dakin binciken sa.

Lokacin da aka tambaye shi game da farfadowar guringuntsi, Jana Wehling ta amsa: “Lallai, muna da hujja a kimiyance game da farfadowar tsoka da jijiya a karkashin ACS Akwai alamun kariya daga guringuntsi da kuma sabuntawa a cikin gwaje-gwajen dabbobi da kuma a aikace-aikacen asibiti na mutum, ”inji ta.

"Amma sabuntawa da guringuntsi yana da matukar wahalar tabbatarwa a karatun asibiti."

Menene bambanci tsakanin Regenokine da PRP far?

PRP far yana jan jininka, yana sarrafa shi don ƙara yawan tarin platelets, sannan a sake saka shi zuwa yankin da abin ya shafa.

Jinin ku yana gudana ta cikin centrifuge don tattara platelets, amma ba a tace shi ba. Ana tunanin cewa yawan nunin platelet yana taimakawa saurin warkar da yankin ta hanyar sakin abubuwan ci gaban da ake bukata.

Ba a amince da PRP ba tukuna ta FDA, kuma yawanci ba inshora ke rufe shi ba. Kudin farashin magani na PRP ya bambanta daga $ 500 zuwa $ 2,000 a kowace allura. Koyaya, ana amfani dashi sau da yawa don magance yanayin musculoskeletal.

. Gidauniyar Arthritis ta lura cewa PRP na iya ɗaukar tsawon watanni 3 zuwa 6. Gidauniyar ta ce "ta fi karfin hyaluronic acid ko kuma corticosteroid injections".

Dakta Laura Timmerman likitan Orthopedic Dakta Laura Timmerman ya sanya ta wannan hanya: PRP "abu ne mai kyau da za a gwada da farko… amma Regenokine yana da kyakkyawar damar samun haƙuri mafi kyawu."

Regenokine yana amfani da daidaitaccen tsarin sarrafawa

Kamar Regenokine, PRP magani ne na ilimin halittu. Jana Wehling ta ce Regenokine tana da tsarin aiki daidai, ba tare da samun sabani ba.

Ya bambanta, an shirya PRP daban-daban tare. Wannan yana da wuya a kwatanta jiyya a karatun kimiyya saboda tsarin PRP ya bambanta.

Regenokine yana cire ƙwayoyin jini da sauran abubuwa masu haɗari

Ba kamar Regenokine ba, PRP ba ta da sel. Ya ƙunshi fararen ƙwayoyin jini da sauran sassan jini waɗanda na iya haifar da kumburi da zafi yayin allurar, a cewar Dokta Thomas Buchheit, a Cibiyar Nazarin Ciwon Fassara ta Jami'ar Duke.

Ya bambanta, Regenokine ya tsarkaka.

Shin Regenokine lafiya?

Amincin Regenokine ba abin tambaya bane, a cewar masana da yawa. Kamar yadda Mayo Clinic’s Evans ya ce: “Abu na farko da ya kamata a sani shi ne cewa yana da lafiya. Ana iya faɗin hakan kwata-kwata. ”

Babu rahoto game da mummunan sakamako a cikin karatun Regenokine.

Ana buƙatar izinin FDA don amfani da Regenokine a Amurka saboda sakewa da jinin ku da aka yi wa magani ana ɗaukar shi magani ne.

Amincewar FDA tana buƙatar ɗimbin karatu da miliyoyin daloli don tallafawa bincike.

Nawa ne kudin Regenokine?

Magungunan Regenokine suna da tsada, kusan $ 1,000 zuwa $ 3,000 a kowace allura, a cewar Jana Wehling.

Cikakken jerin a matsakaita yana da allura huɗu zuwa biyar. Farashin kuma ya bambanta gwargwadon yankin da aka kula da shi da mahimmancinsa. Misali, Jana Wehling ya ce, a cikin kashin baya "muna yin allura a mahaɗa da jijiyoyi da yawa a yayin zama guda."

Ba inshora ya rufe shi a Amurka ba

A Amurka, masu amfani da lasisi na Peter Wehling suna amfani da alamar Regenokine ba tare da lakabi ba. Farashin ya bi na aikin Wehling a Dusseldorf, Jamus, kuma ba a rufe maganin ta hanyar inshora.

Likita mai aikin gyaran jiki Orthomeric Timmerman ya ce tana cajin $ 10,000 don jerin allura don haɗin gwiwa na farko, amma rabin na na biyu ko na gaba. Ta kuma lura cewa ɗaukan jini ɗaya na iya ba ku ƙwayoyin magani da yawa na jini wanda za a iya daskarewa don amfanin gaba.

Kowane shirin magani an "dace da shi" don bukatun mutum, a cewar Jana Wehling. Sauran abubuwan na iya shafar farashin, kamar su "nau'in cuta mai tsanani, yanayin ciwo na mutum, koke-koken asibiti, da kuma cututtukan (cututtukan da suka gabata)."

Ta jaddada cewa burin su shine su kawo farashin.

Har yaushe maganin Regenokine zai wuce?

Ko Regenokine yana buƙatar maimaitawa ya bambanta da mutum da kuma yanayin yanayin ku. Peter Wehling ya kiyasta cewa sauƙaƙewa don gwiwa da kuma amosanin gabbai na iya wucewa tsakanin shekara 1 zuwa 5.

Mutanen da suka amsa da kyau game da maganin galibi suna maimaita shi kowane shekara 2 zuwa 4, in ji Peter Wehling.

A ina zan sami ƙwararren mai ba da sabis?

Ofishin Peter Wehling da ke Dusseldorf, Jamus, lasisi kuma yana duba leburori na likitocin da ke kula da maganin Regenokine a kai a kai. Suna so su tabbatar da cewa an yi maganin daidai kuma a daidaitaccen salon.

Anan ga bayanin tuntuɓar asibitin a Dusseldorf da kuma shafuka uku na Amurka waɗanda ke da lasisi don amfani da maganin:

Dr. Wehling & Abokin Hulɗa
Dusseldorf, Jamus
Peter Wehling, MD, PhD
Imel: [email protected]
Yanar Gizo: https://drwehlingandpartner.com/en/
Waya: 49-211-602550

Duke Tsarin Kula da Ciwon Raɗa
Raleigh, Arewacin Carolina
Thomas Buchheit, MD
Imel: [email protected]
Yanar Gizo: dukerptp.org
Waya: 919-576-8518

Magungunan LifeSpan
Santa Monica, California
Chris Renna, YI
Imel: [email protected]
Yanar Gizo: https://www.lifespanmedicine.com
Waya: 310-453-2335

Laura Timmerman, MD
Gyada Creek, California
Imel: [email protected]
Yanar Gizo: http://lauratimmermanmd.com/-regenokinereg-program.html
Waya: 925- 952-4080

Awauki

Regenokine magani ne don haɗin gwiwa da kumburi. Hanyar aiwatar da jininka don tattara sunadarai masu amfani sannan sanya allurar jinin a cikin yankin da abin ya shafa.

Regenokine ya fi ƙarfi tsari fiye da maganin plasma mai arzikin platelet (PRP), kuma yana yin aiki mafi kyau kuma na tsawon lokaci fiye da PRP.

An amince da Regenokine don amfani a Jamus, inda Dakta Peter Wehling ya inganta shi, amma har yanzu ba ta sami izinin FDA a Amurka ba. An yi amfani da lakabin kashewa a shafuka uku a Amurka waɗanda Wehling ke da lasisi.

Ana buƙatar ƙarin karatu don tabbatar da ingancin Regenokine da samun yardar FDA.

Maganin na da lafiya da tasiri, bisa ga binciken asibiti da masana likitanci. Kuskuren shine Regenokine magani ne mai tsada wanda dole a biya shi daga aljihu a Amurka.